AGP Executive Report
Last update: 11 hours agoMedical Cannabis Access & Regulation: Minnesota’s Office of Cannabis Management met Rochester residents to address rollout concerns, especially public health, packaging/labeling, and keeping products away from kids under 21. Product & Safety Oversight: California’s Department of Cannabis Control is moving to pesticide testing with action levels by individual chemicals, with updated limits and separate standards for inhalable vs non-inhalable products coming next year. Clinical Outcomes: Minnesota reported that autism patients in its medical cannabis program saw drops in anxiety and depression after starting treatment. Industry Expansion: Curaleaf says its TGA-registered liquid medical cannabis inhalation device is now available in Australia and also added to New Zealand’s device database. Market & Legal Pressure: A Missouri judge denied Good Day Farm’s bid to dismiss a customer lawsuit alleging it reduced competition and kept prices high, allowing an amended complaint. Policy Debate: Idaho voters will decide whether the legislature—not ballot initiatives—controls future marijuana and drug law changes. Enforcement & Crime: Europol launched a taskforce targeting rising cannabis smuggling into Europe from North America and Thailand. Community & Philanthropy: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as a nonprofit partner supporting veterans and military families.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.